Latest Breaking News On - Foster mitchell alex shaw - Page 1 : comparemela.com
Pharming Group reports third quarter 2023 financial results Third quarter 2023 revenues increased 23% to US$66.7 million, compared to the third quarter 2022, driven by RUCONEST® revenue and the U.S. commercial launch of Joenja®Nine month year to date 2023 revenues increased 9% to US$164.1 million, compared to nine month year to date 2022RUCONEST® revenues increased 11% in the third quarter 2023 to US$60.2 million, compared to the third quarter 2022, and increased 18% compared to the second quart
CanadaUnited-statesLondonCity-ofUnited-kingdomAmsterdamNoord-hollandNetherlandsJapanAustraliaIsraelAmerica